Photodynamic diagnosis and photodynamic therapy for the brain tumors

DOI Web Site
  • Kuroiwa Toshihiko
    Department of Neurosurgery Osaka Medical College Osaka Medical College Hospital

Bibliographic Information

Other Title
  • 脳腫瘍における光線力学診断と光線力学療法
  • 障害児通所支援事業における作業療法の取り組みについて
  • ショウガイジツウショ シエン ジギョウ ニ オケル サギョウ リョウホウ ノ トリクミ ニ ツイテ

Search this article

Description

Malignant glioma is extremely difficult to treat because of its invasiveness and obscure borders between the tumor and surrounding brain, which are due to a mixture of tumor cells and nerve tissue in the area around the tumor. For surgical removal of malignant glioma, it is important to at least confirm the area of the main mass which is rich in tumor cells. Many methods including frozen section during operation, pre- and intra-operative imaging diagnosis, and navigation system are used for this purpose. Photodynamic diagnosis or photodynamic detection (PDD) is a method that uses various fluorescent dyes such as fluorescein sodium (FS), indocyanine green (ICG), 5-aminofluorescein-albumin conjugate, hematoporphyrin derivatives including porfimer sodium and 5-aminolevulinic acid (5-ALA), and mono-L-aspartyl chlorin e6 (Npe6). We utilize FS and ICG which leak from the tumor vessels due to the breakdown of the blood-brain barrier. The other dyes are selectively incorporated into the brain tumor cells. 5-ALA, an endogenous substance, is the most commonly used dye because it can be orally administered and is relatively safe. While 5-ALA itself does not produce fluorescence, it is metabolized in the cells to protoporphyrin IX producing red fluorescence.Dyes incorporated into the tumor cells are also used for photodynamic therapy (PDT). At present, however, Npe6 is the only dye approved for PDT against brain tumors in Japan.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top